BDO Sets New Standard for Behavioral Health Due Diligence

The Firm

CHICAGO, ILLINOIS, BDO USA reported 2025 revenue of $3.018 billion, a 4.6 percent year-over-year increase, with growth across advisory (3.2 percent), assurance (2.2 percent), and tax (7.7 percent). The firm employs more than 14,000 professionals across more than 85 offices nationwide, making it the sixth-largest accounting firm in the United States. BDO USA is the U.S. member firm of BDO International Limited, one of the world’s largest accounting and advisory organizations, with more than 111,000 people across 1,800 offices in 164 countries and territories.

BDO completed its largest strategic expansion to date in November 2025 with the addition of HORNE LLP, welcoming more than 1,300 professionals and 30 principals. The HORNE combination significantly strengthened BDO’s geographic footprint in the South and Southeast while deepening its government services capabilities in disaster recovery and federal program compliance. The firm also became the first national accounting firm in the United States to establish an Employee Stock Ownership Plan, allowing all employees to hold equity, a structure that supports talent retention in a competitive professional services labor market.

BDO made the Fortune 100 Best Companies to Work For list for the first time in 2025 and returned to the list in 2026, reflecting the firm’s investments in culture, talent development, and employee engagement. The firm’s M&A and Transaction Advisory Services practice provides quality of earnings and cash flow due diligence, tax advisory, integration consulting, financing support, and investment banking services to companies engaged in mergers, acquisitions, and divestitures.

The Behavioral Health Investment Thesis

What distinguishes BDO from other national accounting firms in the ABA transaction advisory space is its explicit intellectual engagement with behavioral health as an investment category. BDO published a detailed analysis titled Understanding the Opportunities and Challenges of Investing in Behavioral Health Services that directly addresses the due diligence concerns PE sponsors face when evaluating behavioral health targets. The publication covers reimbursement trends, revenue recognition complexities, clinical operational models, protected health information handling, and the sustainability assessment that acquirers must perform before committing capital.

The BDO behavioral health investment analysis specifically warns that reported revenue in healthcare transactions may not be supported by actual cash collections and that prospective investors need a deep understanding of the reimbursement trends and related revenue recognition for the target’s specialty. This guidance directly applies to ABA transactions, where Medicaid claims processing timelines, authorization-based billing, and state-specific rate structures create revenue recognition dynamics that differ fundamentally from other service businesses.

BDO’s analysis further recommends that before making a bid, a would-be buyer should assess the sustainability of the business’s earnings by examining historical operating results and the pro forma impact of new payer contracts, new geographies, changes in the location footprint, clinical leverage models, and other recent operational initiatives. For ABA roll-up platforms executing rapid bolt-on acquisitions, this forward-looking analysis of pro forma adjustments is essential to understanding whether the combined platform’s earnings reflect sustainable performance or one-time integration effects.

BDO’s published guidance on behavioral health investing warns that reported revenue may not be supported by actual cash collections and that investors need deep understanding of reimbursement trends and clinical operational models before committing capital, advice that applies directly to ABA platform due diligence.

Quality of Business™ Due Diligence

BDO’s due diligence methodology is branded as Quality of Business™, reflecting an approach that extends beyond traditional quality of earnings analysis to encompass a holistic view of the target’s business value. The Quality of Business framework synthesizes financial due diligence with operational assessment, strategic evaluation, and execution workstream analysis to produce a cohesive, comprehensive view of the target for both buy-side and sell-side engagements.

The framework emphasizes four dimensions. First, speed to insight: BDO’s advanced analytics flag data trends or outliers that may indicate hidden value or areas of risk. Second, data in context: analytics-trained teams translate complex financial data into easy-to-understand visualizations that support stakeholder decision-making. Third, deal perspective: BDO’s deal advisors combine technical due diligence knowledge with deep M&A experience and sector-specific insights. Fourth, holistic vision: the firm synthesizes all diligence and execution workstreams into a unified assessment rather than delivering siloed reports.

For ABA transactions specifically, the Quality of Business approach means that BDO’s diligence report does not simply evaluate whether historical EBITDA is adjustable and sustainable. It also assesses the business drivers that produce those earnings, clinician utilization rates, authorization renewal patterns, payer contracting strategies, geographic market density, and clinical supervision compliance. This integrated assessment provides PE buyers with a more actionable set of diligence findings than a traditional financial-only QofE report.

BDO also provides post-acquisition integration services through its M&A integration and synergy capture practice. The firm supports clients through the entire transaction lifecycle, from due diligence to Day 1 readiness and Day 100 post-merger integration planning and execution, including Integration Management Office operation. For PE-backed ABA platforms executing multiple bolt-on acquisitions per year, this integration capability helps standardize clinical operations, billing systems, and compliance programs across acquired practices.

Healthcare Transaction Advisory Capabilities

BDO’s healthcare transaction advisory team has documented deal experience across multiple healthcare subsectors, including behavioral health, hospice, dental, oncology, orthopedics, pain management, and physician practices. The firm has provided buy-side financial and tax due diligence for private equity sponsors and strategic acquirers on healthcare services transactions and has published sell-side due diligence work for healthcare businesses preparing for exit.

The firm’s transaction advisory capabilities include buy-side and sell-side financial due diligence, tax due diligence, operational due diligence, integration consulting, financing support, and investment banking services through BDO Capital Advisors. BDO’s investment banking arm can serve as a financial advisor on healthcare M&A transactions, providing valuation, deal structuring, and capital markets advisory alongside the firm’s traditional accounting due diligence, an integrated capability that not all mid-market advisory firms offer.

BDO’s Operational Excellence practice provides performance improvement services that extend the firm’s engagement beyond initial diligence into post-acquisition value creation. For ABA platforms where operational standardization, revenue cycle optimization, and clinical workflow improvement represent value creation levers, this operational advisory capability provides continuity from the diligence phase into the hold period.

Where BDO Fits in ABA M&A

BDO occupies a strategic position in the ABA M&A advisory landscape, large enough to provide institutional-quality diligence with deep sector expertise, but positioned in the middle market where the majority of ABA transactions occur. The firm’s $3 billion revenue base and 14,000-professional workforce give it the scale to support multi-state engagements, while its middle-market orientation ensures that fee structures and partner-level attention align with the economics of ABA platform and bolt-on transactions.

The firm competes directly with RSM, Grant Thornton, Baker Tilly, and CohnReznick for middle-market healthcare financial due diligence mandates. BDO’s differentiators include the Quality of Business framework, the explicit behavioral health investment thought leadership, and the investment banking capability through BDO Capital Advisors. For PE sponsors who want financial diligence, operational assessment, and capital markets advisory from a single firm, BDO offers an integrated platform that reduces coordination overhead.

BDO’s ESOP structure may also be a differentiator in attracting and retaining healthcare-experienced due diligence professionals. In a labor market where experienced transaction advisory professionals are in high demand, employee ownership aligns individual incentives with firm performance and may reduce the talent turnover that can affect diligence quality and continuity at competing firms.

BDO occupies a strategic position in ABA M&A, large enough for institutional-quality diligence with deep sector expertise, but oriented toward the middle market where the majority of ABA platform and bolt-on transactions occur.

The regulatory environment facing ABA providers is evolving rapidly, and BDO’s published behavioral health investment guidance anticipated many of the compliance challenges that are now materializing across states. The firm’s emphasis on evaluating clinical leverage models, the supervision ratios, credentialing requirements, and staffing structures that determine how many billable hours an ABA practice can generate, is increasingly relevant as states like Indiana mandate accreditation standards that impose specific requirements on supervision adequacy and clinical documentation.

BDO’s Supply Chain Consulting and Operational Excellence practices, while not healthcare-specific, provide frameworks for operational improvement that PE sponsors can apply to ABA platforms post-acquisition. Revenue cycle optimization, billing process standardization, and clinical workflow efficiency are all operational dimensions where BDO’s performance improvement methodology can drive measurable EBITDA enhancement during the hold period. This post-acquisition value creation capability extends BDO’s engagement beyond the initial diligence into the multi-year investment lifecycle.

The firm’s valuation practice, operated through its Valuation & Capital Market Analysis team, provides fair value assessments, purchase price allocation analysis, goodwill impairment testing, and capital structure optimization advisory. For ABA transactions where goodwill and assembled workforce represent the majority of enterprise value, BDO’s valuation capabilities help buyers understand the composition and defensibility of the target’s intangible asset base. The firm also provides financial modeling and scenario analysis that enables PE sponsors to evaluate multiple investment thesis variations under different assumptions about reimbursement rates, payer mix, and utilization trends.

BDO’s healthcare transaction advisory team brings particular strength to evaluating the reimbursement dynamics that define ABA provider economics. The firm’s published guidance specifically addresses the gap between reported revenue and actual cash collections in healthcare transactions, a dynamic that is endemic to ABA billing, where Medicaid claims processing cycles, prior authorization requirements, and denial management processes all create timing differences between service delivery and cash receipt. BDO’s ability to evaluate these reimbursement dynamics at the diligence level helps PE buyers understand the true cash flow characteristics of an ABA target, not just the accrual-basis earnings reported on the income statement.

Key Considerations for ABA Stakeholders

For ABA practice owners, BDO’s published behavioral health investment guidance provides a valuable preview of how PE buyers and their advisors evaluate behavioral health targets. Owners preparing for a sale should understand BDO’s emphasis on reimbursement sustainability, clinical leverage model assessment, and pro forma impact analysis, these are the dimensions that BDO’s diligence teams will scrutinize when engaged by a buyer.

For PE sponsors, BDO offers a compelling combination of sector-specific thought leadership, a differentiated diligence methodology, and integrated transaction advisory capabilities that span financial, tax, operational, and investment banking services. The firm’s Quality of Business framework is particularly well suited to ABA platform evaluation where earnings sustainability depends on operational factors that a traditional financial QofE may not fully capture.

For the ABA industry, BDO’s willingness to publish detailed guidance on behavioral health investing signals that the firm views the sector as a meaningful and growing component of its healthcare transaction advisory practice. When a top-ten national accounting firm publishes investment guidance specific to a clinical specialty, it reflects sustained institutional demand and validates the maturity of that specialty as an M&A asset class.

BDO’s 2025 revenue growth of 4.6 percent, combined with the HORNE expansion that added more than 1,300 professionals, positions the firm on an accelerating growth trajectory. The firm’s leadership has stated that BDO expects to surpass key performance targets by the end of 2026, reflecting confidence in sustained demand across advisory, tax, and assurance services. For healthcare transaction advisory specifically, this growth trajectory translates into deeper bench strength, broader geographic coverage, and greater capacity to handle multiple simultaneous healthcare due diligence engagements, a practical consideration for PE sponsors executing rapid bolt-on acquisition strategies across their ABA platforms.

The competitive dynamics among middle-market accounting firms in healthcare transaction advisory have intensified as ABA deal volume has grown. RSM, Grant Thornton, Baker Tilly, and CohnReznick all maintain healthcare transaction practices that compete for the same mandates BDO pursues. What separates BDO in this competitive field is the combination of published sector-specific thought leadership, a branded diligence methodology that extends beyond financial analysis, and integrated investment banking capabilities through BDO Capital Advisors that allow the firm to serve clients across the full transaction lifecycle.

For ABA practice owners who are several years away from a potential transaction, BDO’s published behavioral health investment guidance serves as a roadmap for building a business that will withstand the scrutiny of institutional due diligence. The guidance specifically identifies the operational and financial characteristics that sophisticated buyers evaluate, giving owners time to strengthen revenue cycle management, formalize clinical quality metrics, ensure regulatory compliance documentation, and build the kind of management depth that supports premium valuations.

The ESOP ownership structure that BDO pioneered among national accounting firms creates alignment incentives that may be particularly relevant for healthcare advisory engagements. Employee-owners have a direct financial stake in client satisfaction and engagement quality, which can translate into more thorough diligence work and stronger client relationships. For PE sponsors evaluating which advisory firm to engage for a behavioral health platform acquisition, the ESOP structure signals a commitment to long-term quality that pure partnership models may not replicate.

BDO’s integration of post-acquisition services alongside its diligence practice creates continuity that benefits PE sponsors managing ABA platform investments. The transition from diligence findings to integration planning and operational improvement is smoother when the same firm maintains institutional knowledge across both phases. For ABA platforms executing buy-and-build strategies that involve multiple add-on acquisitions, this continuity can compress deal timelines and reduce the risk of integration failures that erode the value thesis.

The growing complexity of ABA reimbursement, spanning commercial insurance, Medicaid managed care, and emerging value-based payment models, makes sector-specific diligence expertise increasingly valuable. Generic financial due diligence that treats ABA revenue as a simple fee-for-service stream will miss the nuances of authorization utilization rates, payer mix concentration risk, rate renegotiation exposure, and the regulatory compliance requirements that can create material financial liabilities for acquirers who fail to identify them during the diligence process.

AT A GLANCE

SOURCES & REFERENCES